Neurological Sciences Department, University of Bologna, Via U Foscolo 7, 40123 Bologna, Italy.
J Headache Pain. 2010 Jun;11(3):207-14. doi: 10.1007/s10194-010-0209-0. Epub 2010 Apr 6.
The Almirall European Headache Awards (AEHA) were organized in conjunction with the European Headache Federation. The awards were held in 2009, aiming to share clinical experience and best practice in headache-related disease management. 56 unusual and challenging cases of headache from 5 European countries (Belgium, France, Italy, Portugal and Spain) were judged by a Scientific Committee including expert representatives from participating countries, acting as reviewers. Three cases were selected from each country. The 15 resulting cases were presented to the Scientific Committee in Madrid, Spain in November 2009 and awards were given to the top 5 presentations. This article presents details of these cases, including the award winning entries. They have been categorized into four main groups: (a) headaches in rare syndromes; (b) secondary headaches to infectious/autoimmune causes or post-trauma/mass occupation; (c) headache in unresolved cases; and (d) other relevant cases. First prize was awarded to a case involving a 55-year-old male with familial thrombocytopenia and a unilateral neuralgiform headache secondary to trigeminal vascular contact, and which was successfully treated with carbamazepine. Conclusions from the meeting include: rare syndromes do occur and require appropriate treatment to improve outcomes; concomitant diseases may impair adequate diagnosis and should be investigated; physicians should be cautious and treat possible serious underlying disease, whilst accurately clarifying the correct diagnosis; neurological examination and complementary tests may be required; consideration should be given to possible rare medication events; and some cases may remain without a clear cause or diagnosis and symptoms should be treated whilst investigations continue.
阿尔米拉尔欧洲头痛奖(AEHA)是与欧洲头痛联合会联合举办的。该奖项于 2009 年设立,旨在分享头痛相关疾病管理方面的临床经验和最佳实践。来自 5 个欧洲国家(比利时、法国、意大利、葡萄牙和西班牙)的 56 例罕见且具有挑战性的头痛病例由一个科学委员会进行评判,该委员会由来自参与国的专家代表组成,担任评审。每个国家选出 3 例。从每个国家选出的 15 例病例提交给 2009 年 11 月在西班牙马德里举行的科学委员会,前 5 名将获得奖项。本文介绍了这些病例的详细信息,包括获奖病例。这些病例被分为四个主要组:(a)罕见综合征中的头痛;(b)继发于感染/自身免疫或外伤/大块占位的头痛;(c)未解决病例中的头痛;和(d)其他相关病例。一等奖授予一名 55 岁男性病例,该患者患有家族性血小板减少症,单侧神经痛样头痛继发于三叉神经血管接触,用卡马西平治疗后成功缓解。会议的结论包括:罕见综合征确实存在,需要进行适当治疗以改善预后;共存疾病可能会影响正确诊断,应进行调查;医生应谨慎对待可能的严重潜在疾病,同时准确明确正确的诊断;可能需要进行神经学检查和补充检查;应考虑可能的罕见药物事件;一些病例可能仍然没有明确的病因或诊断,应在继续调查的同时治疗症状。